| NCT Number | NCT07696962 |
| Lead Sponsor | Xeno Holdings (US), LLC dba ChoironeX |
| Conditions | End Stage Renal Disease |
| Enrollment | 4 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2028-05-30 (estimated) |
| Study Completion | 2028-09-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-10 |